MX2009004770A - Compuestos de carbamato para usarse en el tratamiento de la depresion. - Google Patents

Compuestos de carbamato para usarse en el tratamiento de la depresion.

Info

Publication number
MX2009004770A
MX2009004770A MX2009004770A MX2009004770A MX2009004770A MX 2009004770 A MX2009004770 A MX 2009004770A MX 2009004770 A MX2009004770 A MX 2009004770A MX 2009004770 A MX2009004770 A MX 2009004770A MX 2009004770 A MX2009004770 A MX 2009004770A
Authority
MX
Mexico
Prior art keywords
carbamate compounds
formula
depression
treating depression
treatment
Prior art date
Application number
MX2009004770A
Other languages
English (en)
Inventor
Yong Moon Choi
Robert Gordon
Magali Haas
Ewa Malatynska
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009004770(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2009004770A publication Critical patent/MX2009004770A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención es un método de tratamiento de la depresión, que comprende administrar a un sujeto en necesidad del mismo una cantidad terapéuticamente efectiva de uno o más compuestos de carbamato de fórmula 1 y/o de fórmula 2, como aquí se define y se muestra mas abajo: (ver fórmula (1) y (2)) la presente invención está dirigida a un método de tratamiento de la depresión, que incluye monoterapia y alternativamente coterapia con al menos un antidepresivo adicional.
MX2009004770A 2006-10-30 2007-10-22 Compuestos de carbamato para usarse en el tratamiento de la depresion. MX2009004770A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30
PCT/US2007/082069 WO2008055022A2 (en) 2006-10-30 2007-10-22 Carbamate compounds for use in treating depression

Publications (1)

Publication Number Publication Date
MX2009004770A true MX2009004770A (es) 2009-08-17

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004770A MX2009004770A (es) 2006-10-30 2007-10-22 Compuestos de carbamato para usarse en el tratamiento de la depresion.

Country Status (22)

Country Link
US (1) US20080317883A1 (es)
EP (1) EP2081648A2 (es)
JP (1) JP2010508355A (es)
KR (1) KR20090110889A (es)
CN (1) CN101568362A (es)
AR (1) AR064241A1 (es)
AU (1) AU2007313865A1 (es)
BR (1) BRPI0718324A2 (es)
CA (1) CA2667949A1 (es)
CL (1) CL2007003120A1 (es)
EA (1) EA200970436A1 (es)
EC (1) ECSP099308A (es)
IL (1) IL198484A0 (es)
MX (1) MX2009004770A (es)
NI (1) NI200900073A (es)
NO (1) NO20092018L (es)
PE (1) PE20080929A1 (es)
SV (1) SV2009003247A (es)
TW (1) TW200835477A (es)
UY (1) UY30675A1 (es)
WO (1) WO2008055022A2 (es)
ZA (1) ZA200903771B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP5838226B2 (ja) 2011-01-13 2016-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド フェニルカルバメート誘導体の製造方法
JP2015504054A (ja) * 2011-12-27 2015-02-05 バイオ−ファーム ソリューションズ カンパニー リミテッド 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
KR102014615B1 (ko) * 2013-03-12 2019-08-27 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
CN116478225A (zh) * 2023-04-12 2023-07-25 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
MXPA03007722A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos.
DK1408953T3 (da) * 2001-02-27 2006-08-21 Ortho Mcneil Pharm Inc Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
WO2002067924A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
AU2005302589B2 (en) * 2004-10-28 2010-09-16 Sk Biopharmaceuticals Co., Ltd. Adjunctive therapy for depression

Also Published As

Publication number Publication date
NI200900073A (es) 2010-02-25
CN101568362A (zh) 2009-10-28
NO20092018L (no) 2009-05-26
IL198484A0 (en) 2011-08-01
WO2008055022A3 (en) 2008-06-19
AU2007313865A1 (en) 2008-05-08
ZA200903771B (en) 2010-08-25
BRPI0718324A2 (pt) 2013-11-26
SV2009003247A (es) 2009-11-24
CA2667949A1 (en) 2008-05-08
ECSP099308A (es) 2009-10-30
US20080317883A1 (en) 2008-12-25
KR20090110889A (ko) 2009-10-23
AR064241A1 (es) 2009-03-25
EP2081648A2 (en) 2009-07-29
WO2008055022A2 (en) 2008-05-08
CL2007003120A1 (es) 2008-07-18
EA200970436A1 (ru) 2009-12-30
JP2010508355A (ja) 2010-03-18
PE20080929A1 (es) 2008-07-19
TW200835477A (en) 2008-09-01
UY30675A1 (es) 2008-05-02

Similar Documents

Publication Publication Date Title
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
EA200601746A1 (ru) Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс"
MX2009004770A (es) Compuestos de carbamato para usarse en el tratamiento de la depresion.
HK1141231A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
TW200602048A (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of β -secretase
TW200639159A (en) Treatment of pain
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine
ZA200903652B (en) Methods for treating disruptive behavior disorders
MX2009010164A (es) Metodo para tratar dolor mediado por el receptor cb2.
JO2608B1 (en) Use of different sulfamide derivatives combined with benzo ring to treat depression
MX2009010162A (es) Metodo para tratar dolor mediado por el receptor cb2.
ATE485820T1 (de) Verwendung von n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-inyl min (omigapil) zur prophylaxe und/oder behandlung von muskeldystrophie
UA100552C2 (ru) Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств
ATE468852T1 (de) Lofexidine zur intraspinalen anwendung
TW200738231A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
NO20064828L (no) Ny anvendelse av peptidforbindelser for behandling av smerte i smertefull diabetisk neuropati.
UA95094C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства
BRPI0402756A (pt) método para o tratamento de distúrbios cognitivos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal